LQDA FY 2022 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M+24.0% YoY

Gross Profit

$13M82.1% margin

Operating Income

-$39M-243.3% margin

Net Income

-$41M-257.4% margin

EPS (Diluted)

$-0.67

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$129M

Total Liabilities

$39M

Stockholders' Equity

$90M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$13M	+24.0%
Gross Profit	$13M	$10M	+33.0%
Operating Income	-$39M	-$34M	-14.7%
Net Income	-$41M	-$35M	-18.6%